Adriamycin affects glomerular renal function: evidence for the involvement of oxygen radicals.
The early nephrotoxic effect of the antitumor drug adriamycin (ADR) is suggested to be related to the generation of oxygen free radicals. Therefore the O2-dependence and the influence of free radical scavengers were studied in the model of the isolated perfused single glomerulus of Myxine glutinosa and by histochemical demonstration of the glomerular ATP-ase. In Myxine, the glomerular ATP-ase activity was decreased after injection of ADR (5 mg/kg, i.v.). Both ADR-treated Myxine and controls were exposed for 48 h to an artificial atmosphere of 20% O2/80% N2 or 80% O2/20% N2, respectively. After 10 days a significant decrease of the hydraulic conductivity (k) was measured in the experimental group exposed to 80% O2 (k-values expressed as nl/s.mm Hg.mm2: controls (7): 0.059 +/- 0.017; ADR (7): 0.033 +/- 0.026). The reduction of k following the administration of ADR (20 mg/kg) could be prevented by the sulphydryl donor N-acetylcysteine (NAC). The sieving coefficient for albumin (phi) was significantly increased in ADR-treated animals, showing no O2-dependence (phi x 10(-2): controls (7) 1.3 +/- 0.2; ADR 20% O2 (8): 8.1 +/- 9.6; ADR 80% O2 (7): 6.9 +/- 6.7). phi was not affected by NAC. The lipid peroxide levels in liver, kidney and heart of Myxine increased after the administration of ADR, peaking by day 2 to 5. The circulation disorders of ADR-treated Myxine were not due to an accumulation of the drug in the heart, but rather to a lack of the intracellular antioxidant glutathione. It is concluded that the early nephrotoxic effect of ADR, as reflected by a decreased glomerular ATP-ase activity, is mediated by free radical formation. Oxidative stress on membrane compounds seems to reduce the water permeability of the glomerular barrier, while the ADR-induced sieving defect may be due to oxygen independent pathological mechanisms.
Barbey
M M
MM
Department of Nephrology, Medical School Hannover, FRG.
Fels
L M
LM
Soose
M
M
Poelstra
K
K
Gwinner
W
W
Bakker
W
W
Stolte
H
H
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D004317:Doxorubicin / Q000633:toxicity*; D005609:Free Radicals; D006196:Hagfishes; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D007674:Kidney Diseases / Q000139:chemically induced; D007678:Kidney Glomerulus / Q000187:drug effects* / Q000201:enzymology; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D010100:Oxygen / Q000378:metabolism*; D010477:Perfusion
D005609:Free Radicals; D004317:Doxorubicin; D000251:Adenosine Triphosphatases; D010100:Oxygen